Comparison of Surrogate Serum Markers and Transient Elastography (Fibroscan) for Assessing Cirrhosis in Patients with Chronic Viral Hepatitis
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Progressive hepatic fibrosis with development of cirrhosis is a feature of almost all chronic liver diseases.
We assessed the performance of Fibroscan in patients with chronic viral hepatitis, and in comparison with and combined with several surrogate serum markers for predicting cirrhosis.
In this prospective multicenter cohort study, a novel panel of serum markers was constructed and serum levels of surrogate markers of liver fibrosis and Fibroscan were compared with the stage of fibrosis in the liver biopsy specimens obtained from 121 subjects with chronic viral hepatitis. Another 159 patients were enrolled to validate the diagnostic accuracy of this novel panel.
Multivariate analysis identified platelet count and procollagen III N-terminal peptide (PIIINP) as independent predictors of liver cirrhosis. The PP score (combining of platelet count and PIIINP) showed significantly better diagnostic accuracy (areas under the receiver operating characteristic curves, AUROC: 0.885) than that of previously reported serologic tests, including APRI, Forns fibrosis index, FIB-4 index and ELF algorithm, in the validation group (AUROC: 0.792, 0.740, 0.800, and 0.775, respectively). The AUROC of Fibroscan was 0.743 and the best performance was obtained by combining Fibroscan, platelet count and PIIINP, with an AUROC of 0.826. However, there was no significant difference among the AUROCs of Fibroscan alone, PP score, the combination of Fibroscan and PP score, and previously reported serologic tests in the estimation group.
Fibroscan and surrogate serum markers had similar accuracy for predicting cirrhosis, and combining Fibroscan and serum markers did not improve the accuracy.
- Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995;332:1463–1466. CrossRef
- Ikeda K, Saitoh S, Suzuki Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2215 patients. J Hepatol. 1998;28:930–938. CrossRef
- Niederau C, Lange S, Heintges T, et al. Prognosis of chronic hepatitis C: Results of a large, prospective cohort study. Hepatology. 1998;28:1687–1695. CrossRef
- Benvegnù L, Gios M, Boccato S, et al. Natural history of compensated viral cirrhosis: A prospective study on the incidence and hierarchy of major complications. Gut. 2004;53:744–749. CrossRef
- Giovanna F, Bortolotti F, Francesco D. Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335–352. CrossRef
- Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology. 2002;36:152–160. CrossRef
- Cadrannel JF, Rufat P, Degos F. Practice of liver biopsy in France: Results of a prospective nationwide survey. For the Group of Epidemiology of the France Association for the Study of the Liver(AFEF). Hepatology. 2000;32:477–481. CrossRef
- Castera L, Negre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology. 1999;30:1529–1530. CrossRef
- Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of liver. Lancet. 1986;1:523–525. CrossRef
- Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol. 2003;38:427–432. CrossRef
- The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994;20:15–20. CrossRef
- Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518–526. CrossRef
- Forns X, Ampurdanes S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002;36:986–992.
- Anais VP, Vincent M, Bertrand N, et al. FIB4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007;46:32–38. CrossRef
- William MCR, Michael V, Robert T, et al. Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology. 2004;127:1704–1713. CrossRef
- Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: A meta-analysis. Gastroenterology. 2008;134:960–974. CrossRef
- Kotlyar DS, Blonski W, Rustgi VK. Nnoninvasive monitoring of hepatitis C fibrosis progression. Clin Liver Dis. 2008;12:557–571. CrossRef
- Ogawa E, Furusyo N, Toyoda K, et al. Transient elastography for patients with chronic hepatitis B and C virus infection: Non-invasive, quantitative assessment of liver fibrosis. Hepatol Res. 2007;37:1002–1010. CrossRef
- Lim AK, Pael N, Hamilton G, et al. The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology. 2003;37:788. CrossRef
- Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum proten glycomics. Nat Med. 2004;10:429–434. CrossRef
- Castéra L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–350. CrossRef
- Castéra L. Transient elastography and other noninvasive tests to asses hepatic fibrosis in patients with viral hepatitis. J Viral Hepat. 2009;16:300–314. CrossRef
- Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495–500. CrossRef
- Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289–293. CrossRef
- Castéra L, Le Bail B, Roudot-Thoraval F, et al. Early detection in routine clinical practice of cirrhosis and oeshophageal carices in chronic hepatitis C: Comparison of transient elastography(Fibroscan) with standard laboratory tests and non-invasive scores. J Hepatol. 2009;50:59–68. CrossRef
- Abdel M, Alex F, Robert P. Fibrotest and fibroscan for the prediction of hepatitis C-related fibrosis: A systemic review of diagnostic test accuracy. Am J Gastroenterol. 2007;102:2589–2600. CrossRef
- Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47:380–384. CrossRef
- Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2008;47:592–595. CrossRef
- Roulot D, Czernichow S, Le Clesiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness value in apparently healthy subjects: Influence of gender and metabolic syndrome. J Hepatol. 2008;48:606–613. CrossRef
- de Franchis R. Non-invasive(and minimally invasive) diagnosis of oesophageal varices. J Hepatol. 2008;49:520–527. CrossRef
- Guha IN, Parkes J, Roderick P, et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology. 2008;47:455–460. CrossRef
- Poynard T, Morra R, Halfon P, et al. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol. 2007;7:40. CrossRef
- Kim SU, Ahn SH, Park JY, et al. Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. J Clin Gastroenterol. 2008 Nov 3.
- Comparison of Surrogate Serum Markers and Transient Elastography (Fibroscan) for Assessing Cirrhosis in Patients with Chronic Viral Hepatitis
Digestive Diseases and Sciences
Volume 55, Issue 12 , pp 3552-3560
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Serum markers
- Industry Sectors
- Author Affiliations
- 1. Department of Gastroenterology, Ajou University School of Medicine, San-5 Wonchon-Dong, Youngtoung-Ku, Suwon, 442-721, South Korea
- 2. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea
- 3. Gastroenterology and Hepatology, Hallym University Medical Center, Chuncheon, South Korea
- 4. Institute for Clinical Research, College of Medicine, Pochon CHA University, Seongnam, South Korea
- 5. Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea
- 6. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea